Biohit Oyj — Director's Dealing 2017

Mar 1, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 1, 2017 at 11:45 am local time (EET)

Person subject to the notification requirement
Name: Korpela, Semi
Position: Chief Executive Officer

---

Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170301110708_19

---

Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

---

Transaction details
Transaction date: 2017-02-24
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)

Instrument: Share
ISIN: FI0009005482

Volume: 206
Unit price: 5,61000 Euro
Volume: 258
Unit price: 5,61000 Euro
Volume: 278
Unit price: 5,61000 Euro
Volume: 397
Unit price: 5,61000 Euro
Volume: 500
Unit price: 5,61000 Euro
Volume: 35
Unit price: 5,61000 Euro
Volume: 188
Unit price: 5,61000 Euro
Volume: 465
Unit price: 5,59000 Euro
Volume: 500
Unit price: 5,58000 Euro
Volume: 246
Unit price: 5,65000 Euro
Volume: 298
Unit price: 5,62000 Euro
Volume: 99
Unit price: 5,56000 Euro
Volume: 49
Unit price: 5,56000 Euro
Volume: 500
Unit price: 5,56000 Euro
Volume: 352
Unit price: 5,57000 Euro
Volume: 400
Unit price: 5,62000 Euro

Aggregated transactions
Volume: 4771
Volume weighted average price: 5.59869 Euro

---

Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)

Instrument: Share
ISIN: FI0009005482

Volume: 92
Unit price: 5,40000 Euro
Volume: 95
Unit price: 5,40000 Euro
Volume: 500
Unit price: 5,41000 Euro
Volume: 208
Unit price: 5,42000 Euro
Volume: 550
Unit price: 5,44000 Euro
Volume: 150
Unit price: 5,45000 Euro
Volume: 50
Unit price: 5,45000 Euro
Volume: 140
Unit price: 5,50000 Euro
Volume: 50
Unit price: 5,50000 Euro
Volume: 400
Unit price: 5,51000 Euro
Volume: 540
Unit price: 5,52000 Euro
Volume: 150
Unit price: 5,55000 Euro
Volume: 19
Unit price: 5,55000 Euro
Volume: 10
Unit price: 5,55000 Euro
Volume: 206
Unit price: 5,61000 Euro
Volume: 258
Unit price: 5,61000 Euro
Volume: 278
Unit price: 5,61000 Euro
Volume: 397
Unit price: 5,61000 Euro
Volume: 500
Unit price: 5,61000 Euro
Volume: 35
Unit price: 5,61000 Euro
Volume: 188
Unit price: 5,61000 Euro
Volume: 465
Unit price: 5,59000 Euro
Volume: 500
Unit price: 5,58000 Euro
Volume: 246
Unit price: 5,65000 Euro
Volume: 298
Unit price: 5,62000 Euro

Aggregated transactions
Volume: 6325
Volume weighted average price: 5.54107 Euro

---

Transaction details
Transaction date: 2017-02-28
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)

Instrument: Share
ISIN: FI0009005482

Volume: 268
Unit price: 5,32000 Euro
Volume: 281
Unit price: 5,32000 Euro
Volume: 50
Unit price: 5,32000 Euro
Volume: 177
Unit price: 5,30000 Euro
Volume: 662
Unit price: 5,30000 Euro
Volume: 282
Unit price: 5,31000 Euro
Volume: 404
Unit price: 5,31000 Euro
Volume: 338
Unit price: 5,30000 Euro
Volume: 85
Unit price: 5,31000 Euro
Volume: 200
Unit price: 5,33000 Euro
Volume: 180
Unit price: 5,35000 Euro
Volume: 77
Unit price: 5,35000 Euro
Volume: 800
Unit price: 5,35000 Euro
Volume: 120
Unit price: 5,36000 Euro
Volume: 533
Unit price: 5,35000 Euro
Volume: 125
Unit price: 5,36000 Euro

Aggregated transactions
Volume: 4582
Volume weighted average price: 5.32617 Euro

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com